Search Results

You searched for : pembrolizumab  

	How the Immune System is Transforming Cancer Treatment Immunotherapy is a drug used in the treatment of cancer. It is a new modality of treatment. immunotherapy is given intravenously (injection) usually at 2 ... Jun 30
	How Targeted Therapy & Immunotherapy Are Transforming Lymphoma Care Cancer is a serious global health issue, and specialists are constantly exploring for more effective and less hazardous treatment options.... Sep 15
	Zumutor Biologics Advances Cancer Care with Novel Immunotherapy ZM008: A First-in-Class Anti LLT1 Antibody As the ZM008-001 clinical trial progresses, the medical community eagerly awaits the results, which could lead the way for a new era in cancer ... Jun 13
	Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients Latest news updates... Oct 26
	Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106 Latest Pharma Update... Aug 23
	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ... Jul 12
	M2GEN announces new collaboration with Merck to advance Cancer therapies Another pharma collaboration for the advancement of cancer therapies ... Mar 22
	BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic virus BT-001 in solid tumors BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
	KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival ... Dec 16
	KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
	BriaCell announces the overall breast cancer survival (OS) data of its lead product candidate, Bria-IMT™ Median OS of 13.3 months has been observed in the Phase I/IIa study for patients treated with Bria-IMT™ in combination with immune ... Oct 21
	PharmAbcine entered into a strategic partnership with Samsung Biologic PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibodies to treat cancer and neovascular disease... Sep 22
	PharmAbcine signs a CMO contract with Binex for Olinvacimab production Binex will produce olinvacimab at its new 5,000L production line... Sep 03
	Merck’s KEYTRUDA Receives Two New Approvals in Japan Keytruda would be soon launched in Japan for the treatment of cancerous tumors... Aug 27
	Singapore cancer drug ETC-159 advances further in clinical trials First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours ... Jul 31
	PharmAbcine signs manufacturing agreement with Binex PharmAbcine signs long-term contract manufacturing organization agreement for Olinvacimab with Binex ... Jun 27
	Merck Innovates Breakthrough in Cancer Care Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 ... May 14
	IASLC World Conference on Lung Cancer--Press Briefing Summary from Sunday, September 8th ... Sep 13
	Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ... Sep 10
19 Matching result(s) found!

Trending Now
	Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
	Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026
	Prostate Health Awareness: What Every Indian Man Needs to KnowAugust 07, 2026
	Testosterone Levels Explained: Normal Ranges by Age, Causes of Imbalance, and What to DoAugust 07, 2026
	“AI can read a chest X-ray in 1.3 seconds” says Dr. Marios Loukas, President and Dean of the School of Medicine, St. George’s UniversityAugust 06, 2026
	UK Mental Healthcare Leader Care ADHD To Open Its First Clinic in Bengaluru This October, Bringing NHS-Backed ADHD Care Model to IndiaAugust 06, 2026
	Aster DM Quality Care Reports Strong Q1 FY27: Revenue Up 20 Per Cent to Rs 2,597 Cr, Operating EBITDA Up 30 Per CentAugust 06, 2026
	What Happens to Your Body During an All-Nighter?August 06, 2026
	Childhood Obesity in India: A Growing Public Health Crisis That Demands Urgent AttentionAugust 06, 2026
	Screen Time Effects on Children: What Every Indian Parent and Paediatrician Needs to KnowAugust 06, 2026
	Kidney Transplant Recipient Defeats CancerAugust 05, 2026
	Fermenta Biotech Lists on India’s National Stock ExchangeAugust 05, 2026
	Asia Pacific leaders warn attacks against health and gender are undoing decades of progressAugust 05, 2026
	Understanding Long-Term Impacts of Air Purification on ImmunityAugust 05, 2026
	Understanding Epigenetics: How Lifestyle Changes Your DNAAugust 05, 2026
	CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
	Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
	Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
	Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
	A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026